BioLab 612 LLC Report issue

For profit Phase 2
Founded: Moscow Russian Federation (2003)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2015
NCT02715882
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now